ANTWERP, Belgium & DRESDEN, Germany–(BUSINESS WIRE)–Minze Health, a leader in digital diagnostics and therapeutics for urology, and Apogepha Arzneimittel GmbH (“Apogepha”), a family-owned specialty pharmaceutical company focused on urology, today announced a joint development agreement to co-develop and commercialize a prescription digital therapeutic (DTx) for men suffering from Lower Urinary Tract Symptoms (LUTS). This partnership merges Minze’s evidence-based digital health platform and in